Sanofi SA (SNY) reports a 7% revenue increase, with significant contributions from DUPIXENT and new product launches, despite ...

Sanofi posted strong Q3 results amid currency challenges; discover key pipeline updates and growth prospects for investors.

Sanofi’s Q3 saw total revenues rise 7% CER, with Dupixent contributing over €4 billion for the first time. Click here to read ...

The French pharma’s overall vaccine sales declined 8% in the quarter, with a key driver being slower-than-usual uptake of flu ...

Sanofi stock jumped early Friday on better-than-expected third-quarter sales and earnings, and a strong showing from Dupixent ...

Health-care companies ticked up after a generally strong round of earnings. Hospital chain HCA Healthcare boosted its full-year growth outlook after logging higher profit and revenue in the third ...

Medidata will be expanding its long-standing partnership with Sanofi, now leveraging Medidata Patient, Data, and Study Experiences within the collaboration. The ecosystem of tools aims to address ...

Fintel reports that on October 24, 2025, Cantor Fitzgerald initiated coverage of Novavax (NasdaqGS:NVAX) with a Overweight ...

Female sex is associated with up to 44% increased odds of chronic rhinosinusitis without nasal polyps (CRSsNP), but 37% ...

At the close, the Dow Jones Industrial Average was up 1.01% at 47,207.12, while the S&P 500 advanced 0.79% to 6,791.69, and ...

Tata Capital, Maruti Suzuki India, Urban Company, NTPC, Bank of Baroda and Cipla are among over 300 companies scheduled to ...